Response characteristics in patients with HL receiving nivolumab for a relapse after allo-HCT. PFS of the 20 patients included in this study. The color of each bar indicates the presence and the type of GVHD history. The length of the bar shows the time between nivolumab initiation and progression or death (regardless of the cause).